The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Guidelines for the Preanalytical Conditions for Analyzing Circulating Cell-Free DNA
Open accessAbstract
Circulating cell-free DNA (cfDNA) isolated from blood has been identified as a potential biomarker in numerous fields, and has been the object of intensive research over the past decade, although its original discovery dates back 60 years. While it is already used routinely in commercial and clinical practice in oncology and prenatal testing, other potential applications have emerged, including for diabetes, cardiovascular diseases, organ transplantation, autoimmune diseases, sepsis, trauma, and sport management. As with the discovery and development of any biomarker, preanalytical requirements and documentation are as important as analytical requirements. Except for the case of noninvasive prenatal testing and prenatal diagnosis, the implementation of cfDNA in a clinical setting remains limited because of the lack of standardization of cfDNA analysis. In particular, only a few attempts have been made to collect and pool scientific data on the relevant preanalytical factors, and no standard operating procedure has yet been set. For this report, we have performed a thorough and systematic search via MEDLINE® for relevant preanalytical variables and patient factors. These form the basis of the guidelines we propose for analyzing nuclear cfDNA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Presence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
(1977) · PubMed · Cited by 1,801
Lo, Y. M. D., Tein, M. S. C., Lau, T. K., Haines, C. J., Leung, T. N., Poon, P. M. K., Wainscoat, J. S., Johnson, P. J., Chang, A. M. Z., & Hjelm, N. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301800 · Cited by 1,653
Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Merker, J. D., Oxnard, G. R., Compton, C., Diehn, M., Hurley, P., Lazar, A. J., Lindeman, N., Lockwood, C. M., Rai, A. J., Schilsky, R. L., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.8671 · Cited by 959
Origins, structures, and functions of circulating DNA in oncology
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9629-x · Cited by 818
Self-citationHigh Fragmentation Characterizes Tumour-Derived Circulating DNA
Mouliere, F., Robert, B., Arnau Peyrotte, E., Del Rio, M., Ychou, M., Molina, F., Gongora, C., & Thierry, A. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023418 · Cited by 567
Self-citationCirculating cell free DNA: Preanalytical considerations
El Messaoudi, S., Rolet, F., Mouliere, F., & Thierry, A. R. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.022 · Cited by 560
Self-citationCirculating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection
De Vlaminck, I., Valantine, H. A., Snyder, T. M., Strehl, C., Cohen, G., Luikart, H., Neff, N. F., Okamoto, J., Bernstein, D., Weisshaar, D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007803 · Cited by 549
Isolation and characterization of DNA from the plasma of cancer patients
Stroun, M., Anker, P., Lyautey, J., Lederrey, C., & Maurice, P. A. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90266-5 · Cited by 373 · cited 1×
“In red, specific application requirements: (1) detection of a specific normal sequence; (2) detection of genetic alterations; (3) detection of epigenetic alterations; (4) quantification; (5) determination of fragmentation level.”
BackgroundNext-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection
Aravanis, A. M., Lee, M., & Klausner, R. D. (2017) · Cell · doi:10.1016/j.cell.2017.01.030 · Cited by 367
Effects of Blood-Processing Protocols on Fetal and Total DNA Quantification in Maternal Plasma
Chiu, R. W. K., Poon, L. L. M., Lau, T. K., Leung, T. N., Wong, E. M. C., & Lo, Y. M. D. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.9.1607 · Cited by 351
on behalf of the European Society of Human Genetics (ESHG) and the American Society of Human Genetics (ASHG), Dondorp, W., de Wert, G., Bombard, Y., Bianchi, D. W., Bergmann, C., Borry, P., Chitty, L. S., Fellmann, F., Forzano, F., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.57 · Cited by 349
Sequencing of Circulating Cell-free DNA during Pregnancy
Bianchi, D. W., & Chiu, R. W. K. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705345 · Cited by 313
Lee, T., Montalvo, L., Chrebtow, V., & Busch, M. P. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41020276.x · Cited by 311
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts
Thierry, A. R., Mouliere, F., Gongora, C., Ollier, J., Robert, B., Ychou, M., Del Rio, M., & Molina, F. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq421 · Cited by 299
Self-citationDevonshire, A. S., Whale, A. S., Gutteridge, A., Jones, G., Cowen, S., Foy, C. A., & Huggett, J. F. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7835-3 · Cited by 299
Quantifying circulating cell-free DNA in humans
Meddeb, R., Dache, Z. A. A., Thezenas, S., Otandault, A., Tanos, R., Pastor, B., Sanchez, C., Azzi, J., Tousch, G., Azan, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41593-4 · Cited by 240
Self-citationChanges in Concentration of DNA in Serum and Plasma during Storage of Blood Samples
Jung, M., Klotzek, S., Lewandowski, M., Fleischhacker, M., & Jung, K. (2003) · Clinical Chemistry · doi:10.1373/49.6.1028 · Cited by 233
Mouliere, F., El Messaoudi, S., Pang, D., Dritschilo, A., & Thierry, A. R. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.02.005 · Cited by 230
Self-citationNon-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA
Zemmour, H., Planer, D., Magenheim, J., Moss, J., Neiman, D., Gilon, D., Korach, A., Glaser, B., Shemer, R., Landesberg, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03961-y · Cited by 226
Circulating cell-free nucleic acids: characteristics and applications
Pös, O., Biró, O., Szemes, T., & Nagy, B. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0132-4 · Cited by 215
Cell-free DNA: Preanalytical variables
Bronkhorst, A. J., Aucamp, J., & Pretorius, P. J. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.08.028 · Cited by 183
Evaluation of pre-analytical factors affecting plasma DNA analysis
Markus, H., Contente‐Cuomo, T., Farooq, M., Liang, W. S., Borad, M. J., Sivakumar, S., Gollins, S., Tran, N. L., Dhruv, H., Berens, M. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25810-0 · Cited by 171
Preanalytical Variables Affecting the Integrity of Human Biospecimens in Biobanking
Ellervik, C., & Vaught, J. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.228783 · Cited by 167
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
Mouliere, F., El Messaoudi, S., Gongora, C., Guedj, A.-S., Robert, B., Del Rio, M., Molina, F., Lamy, P.-J., Lopez-Crapez, E., Mathonnet, M., et al. (2013) · Translational Oncology · doi:10.1593/tlo.12445 · Cited by 159
Self-citationBarra, G. B., Rita, T. H. S., Vasques, J. D. A., Chianca, C. F., Nery, L. F. A., & Costa, S. S. S. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.02.014 · Cited by 149
DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer
Leygo, C., Williams, M., Jin, H., Chan, M. W. Y., Chu, W. K., Grusch, M., & Cheng, Y. Y. (2017) · Disease Markers · doi:10.1155/2017/3726595 · Cited by 140
Maruchi, Y., Tsuda, M., Mori, H., Takenaka, N., Gocho, T., Huq, M. A., & Takeyama, N. (2018) · Critical Care · doi:10.1186/s13054-018-2109-7 · Cited by 134
Anticoagulants Interfere with PCR Used To Diagnose Invasive Aspergillosis
García, M. E., Blanco, J. L., Caballero, J., & Gargallo‐Viola, D. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1567-1568.2002 · Cited by 123
Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?
Yang, M., Forbes, M. E., Bitting, R. L., O’Neill, S. S., Chou, P. C., Topaloĝlu, Ü., Miller, L. D., Hawkins, G. A., Grant, S. C., DeYoung, B. R., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx766 · Cited by 108
Thierry, A. R., Pastor, B., Jiang, Z.-Q., Κατσιαμπούρα, Α., Parseghian, C. M., Loree, J. M., Overman, M. J., Sánchez, C., Messaoudi, S. E., Ychou, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0232 · Cited by 106
Self-citationSánchez, C., Snyder, M. W., Tanos, R., Shendure, J., & Thierry, A. R. (2018) · npj Genomic Medicine · doi:10.1038/s41525-018-0069-0 · Cited by 101
Self-citationAlidousty, C., Brandes, D., Heydt, C., Wagener‐Ryczek, S., Wittersheim, M., Schäfer, S. C., Holz, B., Merkelbach‐Bruse, S., Büttner, R., Fassunke, J., et al. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.06.004 · Cited by 94
Sze, M. A., Abbasi, M., Hogg, J. C., & Sin, D. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110351 · Cited by 91
Demuth, C., Spindler, K. G., Johansen, J. S., Pallisgaard, N., Nielsen, D. L., Høgdall, E. V. S., Vittrup, B., & Sørensen, B. S. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.07.013 · Cited by 83
Circulating, cell-free DNA as a marker for exercise load in intermittent sports
Haller, N., Helmig, S., Taenny, P., Petry, J., Schmidt, S., & Simon, P. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191915 · Cited by 75
DNA Integrity in Plasma and Serum of Patients with Malignant and Benign Diseases
Holdenrieder, S., Burges, A., Reich, O. M., Spelsberg, F. W., & Stieber, P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.013 · Cited by 72
Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
Catarino, R., Coelho, A., Araújo, A., Gomes, M. P., Nogueira, A., Lopes, C., & Medeiros, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038559 · Cited by 70
Burns, W. R., Koelper, N., Barberio, A., Deagostino‐Kelly, M., Mennuti, M. T., Sammel, M. D., & Dugoff, L. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5152 · Cited by 64
Fetal fraction evaluation in non-invasive prenatal screening (NIPS)
Hestand, M. S., Bessem, M., van Rijn, P., de Menezes, R. X., Sie, D., Bakker, I. M. C., Boon, E. M. J., Sistermans, E. A., & Weiss, M. M. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0271-7 · Cited by 63
on behalf of the European Society of Human Genetics (ESHG) and the American Society of Human Genetics (ASHG), Dondorp, W., de Wert, G. M. W. R., Bombard, Y., Bianchi, D. W., Bergmann, C., Borry, P., Chitty, L. S., Fellmann, F., Forzano, F., et al. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.109 · Cited by 61
Detection of circulating fetal nucleic acids: a review of methods and applications
Hung, E., Chiu, R. W. K., & Lo, Y. M. D. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048470 · Cited by 56
Danese, E., Minicozzi, A. M., Benati, M., Montagnana, M., Paviati, E., Salvagno, G. L., Gusella, M., Pasini, F., Guidi, G. C., & Lippi, G. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.351 · Cited by 55
ASBL, O. B. O. I. P., Keppens, C., Dequeker, E. M. C., Patton, S. J., Normanno, N., Fenizia, F., Butler, R., Cheetham, M. H., Fairley, J. A., Williams, H. L., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4694-x · Cited by 52
Nguyen, D. N., Stensballe, A., Lai, J. C. Y., Jiang, P., Brunse, A., Li, Y., Sun, J., Mallard, C. E., Skeath, T., Embleton, N. D., et al. (2017) · Innate Immunity · doi:10.1177/1753425917719995 · Cited by 51
Livesey, J. H., Ellis, M. J., & Evans, M. J. (2008) · PubMed · Cited by 50
Aucamp, J., Bronkhorst, A. J., Badenhorst, C. P. S., & Pretorius, P. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2370-3 · Cited by 49
Lee, H., Na, W., Park, C., Park, K. H., & Shin, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-23766-9 · Cited by 42
Manokhina, I., Singh, T. K., Peñaherrera, M. S., & Robinson, W. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101500 · Cited by 41
Caboux, É., Lallemand, C., Ferro, G., Hémon, B., Mendy, M., Biessy, C., Sims, M., Wareham, N. J., Britten, A., Boland, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039821 · Cited by 39
New frontiers for platelet CD154
Dewitte, A., Tanga, A., Villeneuve, J., Lepreux, S., Ouattara, A., Desmoulière, A., Combe, C., & Ripoche, J. (2015) · Experimental Hematology and Oncology · doi:10.1186/s40164-015-0001-6 · Cited by 38
Does Centrifugation Cause the ex Vivo Release of DNA from Blood Cells?
Lui, Y. Y.-N., Chik, K.-W., & Lo, Y. D. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.11.2074 · Cited by 29
Differentially methylated circulating DNA: A novel biomarker to monitor beta cell death
Liu, Y., Tan, Q., & Liu, F. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.08.012 · Cited by 14
Relationship Between Cardiovascular Diseases and Circulating Cell-Free Nucleic Acids in Human Plasma
Biró, O., Hajas, O., Nagy-Baló, E., Soltész, B., Csanádi, Z., & Nagy, B. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0386 · Cited by 12
Pre-analytical Requirements for Analyzing Nucleic Acids from Blood
Messaoudi, S. E., & Thierry, A. R. (2014) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-017-9168-7_3 · Cited by 9
Self-citation
Cited by
Liquid biopsy enters the clinic — implementation issues and future challenges
Ignatiadis, M., Sledge, G. W., & Jeffrey, S. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00457-x · Cited by 1,191
DNA Methylation Cancer Biomarkers: Translation to the Clinic
Locke, W. J., Guanzon, D., Ma, C., Liew, Y. J., Duesing, K. R., Fung, K. Y. C., & Ross, J. P. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01150 · Cited by 472
Blood contains circulating cell‐free respiratory competent mitochondria
Al Amir Dache, Z., Otandault, A., Tanos, R., Pastor, B., Meddeb, R., Sanchez, C., Arena, G., Lasorsa, L., Bennett, A., Grange, T., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201901917rr · Cited by 383
Self-citationDasari, A., Morris, V. K., Allegra, C. J., Atreya, C., Benson, A. B., Boland, P., Chung, K., Copur, M. S., Corcoran, R. B., Deming, D. A., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0392-0 · Cited by 372
How liquid biopsies can change clinical practice in oncology
Siravegna, G., Mussolin, B., Venesio, T., Marsoni, S., Seoane, J., Dive, C., Papadopoulos, N., Kopetz, S., Corcoran, R. B., Siu, L. L., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz227 · Cited by 358
Metadata
- Authors
- Meddeb, R., Pisareva, E., & Thierry, A. R.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-05-01
- Volume
- 65
- Issue
- 5
- Pages
- 623-633
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2917797993
- Cited by
- 262
- References
- 57
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.